Ebola virus infection of the female reproductive system
埃博拉病毒感染女性生殖系统
基本信息
- 批准号:10396086
- 负责人:
- 金额:$ 23.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-21 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAfricaAfricanAirAnimal ModelAutomobile DrivingAwarenessBiochemicalBiological AssayBloodCell Differentiation processCellsCessation of lifeCharacteristicsChemotaxisClinicalCoitusConsentCounselingDataDemocratic Republic of the CongoDevelopmentDiseaseDisease OutbreaksEbola Hemorrhagic FeverEbola virusEnvironmentEpithelialEpithelial CellsExperimental ModelsFDA approvedFamilyFamily memberFiloviridae InfectionsFilovirusFlareFollow-Up StudiesGoalsGrantHumanImmuneImmune TargetingImmunocompetentIn VitroInbred BALB C MiceInfectionInflammationInflammation MediatorsInflammatory ResponseInterferonsKnowledgeLaboratoriesLesionLiquid substanceMediatingMethodsModelingMonitorMusOnset of illnessPathogenesisPathogenicityPathway interactionsPatient IsolationPredispositionReportingResearchRoleRouteSeminal fluidSeveritiesSex BehaviorSexual TransmissionSexually Transmitted DiseasesSurvivorsSystemic infectionTestingTherapeuticTimeTissuesVaccinesVaginaViral GenomeViral Hemorrhagic FeversViral PathogenesisViremiaVirusVirus DiseasesVirus ReplicationWomanWorkanti-viral efficacycondomsepidemiologic dataexposure routefemale reproductive systemgenomic datahuman femalehuman modelin vitro Modelin vivoin vivo Modelmalemathematical modelmicrobicidemortalitymouse modelnovelpreventprogramsprophylacticrecruitresponsethree-dimensional modelingtransmission processviral transmission
项目摘要
SUMMARY/ABSTRACT
Ebola virus (family Filoviridae) is the causative agent of Ebola virus disease (EVD), which is characterized by
hemorrhagic fever in humans, reaching high mortality rates (≥40%). Sexual transmission of Ebola virus from a
male survivor to a woman was first documented during the large 2014-2016 West African outbreak. Then this
route of infection was reported to be likely responsible for multiple EBOV outbreak flare-ups between 2015 and
2016. Infectivity of the semen of survivors was later documented for at least 179 days after the onset of disease.
Mathematical modelling of the contribution of sexual behavior in virus transmission during that same outbreak
showed that abstinence, along with infectious patient isolation, could stop an outbreak. As of June 2nd, 2020, the
on-going EBOV outbreak in the Democratic Republic of the Congo describes 3463 cases with 2280 deaths, and
there are no data available as to which route of infection is primarily responsible of transmission and the
situational awareness of survivors to spread EVD. Recently, our group demonstrated that human vaginal
epithelial cells are susceptible to infection with Ebola virus, support productive viral replication resulting in a
robust proinflammatory response. Furthermore, we evaluated the antiviral efficacy of the vaginal Polyphenylene
Carboxymethylene (PPCM) microbicide as a countermeasure and could show suppression of virus replication
and virus-induced inflammatory response in these cells. Altogether, these facts support the critical need to
develop new experimental models for this route of infection and therapeutics preventing virus transmission during
unprotected sexual intercourse.
Our long-term goal is to better understand sexual transmission of Ebola virus, and to identify prophylactic
methods other than condoms. The objective in this proposal is to investigate Ebola virus pathogenesis in women
following sexual transmission using a relevant in-vitro model of the human female reproductive system as well
as a susceptible mouse model. Our central hypothesis is that the human female reproductive system is
susceptible to Ebola virus infection leading to atypical clinical manifestations of EVD and laboratory
characteristics compared to those observed after infection by Ebola virus using other more documented routes
of infection. To interrogate our driving hypothesis, we propose the following Specific Aims: (1) Characterize
Ebola virus infection and inflammation in-vitro using a model of the human vaginal epithelium cultured
at air-liquid interface, (2) Establish an in-vivo model of Ebola Virus Disease (EVD) following intravaginal
virus challenge, and (3) Evaluate the protective antiviral efficacy of PPCM in-vitro and in-vivo. The
proposed studies will develop novel models for research of filovirus pathogenicity and further develop PPCM as
a microbicide for Ebola virus infection.
总结/摘要
埃博拉病毒(丝状病毒科)是埃博拉病毒病(EVD)的病原体,其特征在于:
人类出血热,死亡率高达40%以上。埃博拉病毒的性传播
在2014-2016年西非大爆发期间首次记录了男性幸存者对女性的影响。那么这
据报道,感染途径可能是2015年至2019年期间多次EBOV爆发的原因。
2016.幸存者的精液活力后来被记录为至少179天后的疾病发作。
在同一次爆发期间,性行为在病毒传播中所起作用的数学模型
表明,禁欲,沿着传染病患者隔离,可以阻止疫情的爆发。截至2020年6月2日,
刚果民主共和国正在发生的埃博拉病毒疫情描述了3463例病例,2280例死亡,
没有数据表明哪种感染途径是主要的传播途径,
幸存者的情况意识,以传播EVD。最近,我们的团队证明了人类阴道
上皮细胞易受埃博拉病毒感染,支持生产性病毒复制,
强烈的促炎反应。此外,我们评估了阴道聚苯的抗病毒效果,
羧甲基(PPCM)杀微生物剂作为对策,可抑制病毒复制
和病毒诱导的炎症反应。总而言之,这些事实支持迫切需要
为这种感染途径开发新的实验模型,并开发预防病毒传播的治疗方法,
无保护的性交
我们的长期目标是更好地了解埃博拉病毒的性传播,
避孕套以外的方法。该提案的目的是调查妇女中埃博拉病毒的发病机制
性传播后,也使用人类女性生殖系统的相关体外模型,
作为易感小鼠模型。我们的中心假设是,人类女性生殖系统是
易受埃博拉病毒感染,导致EVD的非典型临床表现,
与使用其他更有记录的途径感染埃博拉病毒后观察到的特征相比,
感染为了质疑我们的驱动假说,我们提出了以下具体目标:(1)表征
使用培养的人阴道上皮细胞模型进行体外埃博拉病毒感染和炎症
(2)建立阴道内注射后的埃博拉病毒病(Ebola Virus Disease,EVD)体内模型
病毒攻击;(3)评价PPCM在体外和体内的抗病毒保护效力。的
拟议的研究将开发用于丝状病毒致病性研究的新模型,并进一步开发PPCM,
一种治疗埃博拉病毒感染的杀菌剂
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Susceptibility of BALB/c Mice to a Mouse-Adapted Ebola Virus Intravaginal Infection.
- DOI:10.3390/v15071590
- 发表时间:2023-07-21
- 期刊:
- 影响因子:0
- 作者:Escaffre O;Juelich TL;Smith JK;Zhang L;Bourne N;Freiberg AN
- 通讯作者:Freiberg AN
Characterization of an air-liquid interface primary human vaginal epithelium to study Ebola virus infection and testing of antivirals.
- DOI:10.1016/j.antiviral.2023.105551
- 发表时间:2023-03
- 期刊:
- 影响因子:7.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Niclas Freiberg其他文献
Alexander Niclas Freiberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Niclas Freiberg', 18)}}的其他基金
Therapeutic efficacy of favipiravir against henipavirus infections
法匹拉韦对亨尼帕病毒感染的治疗效果
- 批准号:
10289470 - 财政年份:2021
- 资助金额:
$ 23.7万 - 项目类别:
Ebola virus infection of the female reproductive system
埃博拉病毒感染女性生殖系统
- 批准号:
10196662 - 财政年份:2021
- 资助金额:
$ 23.7万 - 项目类别:
Role of Reactive Oxygen Species in Nipah Virus Pathogenesis
活性氧在尼帕病毒发病机制中的作用
- 批准号:
8911773 - 财政年份:2014
- 资助金额:
$ 23.7万 - 项目类别:
Bioavailable proteasome inhibitors as broad-spectrum antivirals
生物可利用的蛋白酶体抑制剂作为广谱抗病毒药物
- 批准号:
9091400 - 财政年份:2012
- 资助金额:
$ 23.7万 - 项目类别:
Bioavailable proteasome inhibitors as broad-spectrum antivirals
生物可利用的蛋白酶体抑制剂作为广谱抗病毒药物
- 批准号:
8653759 - 财政年份:2012
- 资助金额:
$ 23.7万 - 项目类别:
Bioavailable proteasome inhibitors as broad-spectrum antivirals
生物可利用的蛋白酶体抑制剂作为广谱抗病毒药物
- 批准号:
8391397 - 财政年份:2012
- 资助金额:
$ 23.7万 - 项目类别:
相似海外基金
African Rare Diseases Initiative (ARDI): Advancing Genomic Medicine through rare diseases research in Africa
非洲罕见疾病倡议 (ARDI):通过非洲罕见疾病研究推进基因组医学
- 批准号:
10674660 - 财政年份:2023
- 资助金额:
$ 23.7万 - 项目类别:
French foreign policy in West-Africa revisited: examining French monetary and military influence on African sovereignty
重新审视法国在西非的外交政策:审视法国货币和军事对非洲主权的影响
- 批准号:
2887041 - 财政年份:2023
- 资助金额:
$ 23.7万 - 项目类别:
Studentship
Seamen from the African Indian Ocean, 1880s-1940s: Transnational Labour Relations between Africa and Europe in Colonial Times
来自非洲印度洋的海员,1880 年代至 1940 年代:殖民时期非洲和欧洲之间的跨国劳资关系
- 批准号:
23K00793 - 财政年份:2023
- 资助金额:
$ 23.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role of Kaiso as a predictive breast cancer biomarker in Africa and across the African Diaspora
Kaiso 作为非洲和整个非洲侨民的乳腺癌预测生物标志物的作用
- 批准号:
10347874 - 财政年份:2022
- 资助金额:
$ 23.7万 - 项目类别:
Pan-African Frontiers And Identities: The Remaking Of Africa In World Politics
泛非边界和身份:世界政治中非洲的重塑
- 批准号:
MR/W012103/1 - 财政年份:2022
- 资助金额:
$ 23.7万 - 项目类别:
Fellowship
Southern African Research Consortium for Mental health INTegration (S-MhINT)-Research and capacity building consortium to strengthen mental health integration in South Africa, Mozambique and Tanzania.
南部非洲心理健康一体化研究联盟 (S-MhINT) - 研究和能力建设联盟,旨在加强南非、莫桑比克和坦桑尼亚的心理健康一体化。
- 批准号:
10613603 - 财政年份:2022
- 资助金额:
$ 23.7万 - 项目类别:
The timing and geography of African ape and human origins: New evidence from Europe, Africa and Asia.
非洲猿和人类起源的时间和地理:来自欧洲、非洲和亚洲的新证据。
- 批准号:
RGPIN-2016-06761 - 财政年份:2021
- 资助金额:
$ 23.7万 - 项目类别:
Discovery Grants Program - Individual
The definition of "Africa" and the concept of "race" in Pan-African movements
“非洲”的定义与泛非运动中的“种族”概念
- 批准号:
20K22009 - 财政年份:2020
- 资助金额:
$ 23.7万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Re-examining the anti-colonial discourses in former Portuguese Africa: How African press argued
重新审视前葡属非洲的反殖民话语:非洲媒体如何争论
- 批准号:
20K12353 - 财政年份:2020
- 资助金额:
$ 23.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The timing and geography of African ape and human origins: New evidence from Europe, Africa and Asia.
非洲猿和人类起源的时间和地理:来自欧洲、非洲和亚洲的新证据。
- 批准号:
RGPIN-2016-06761 - 财政年份:2020
- 资助金额:
$ 23.7万 - 项目类别:
Discovery Grants Program - Individual